You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD4 CD28null T-cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    CNS Lymphoma Trial in Duarte (procedure, biological, drug)

    Recruiting
    • Central Nervous System Lymphoma
    • Aspiration
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

    Recruiting
    • T-cell Lymphoma
    • T-cell Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Dec 16, 2022

    Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • CHM-1101 CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Dec 19, 2022

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    Has Results
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Acalabrutinib
    • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Jun 16, 2022

    Psoriasis Trial in Sohag (skin biopsy)

    Not yet recruiting
    • Psoriasis
    • skin biopsy
    • Sohag, Egypt
      Sohag university Hospital
    Sep 21, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Oct 13, 2023

    B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

    Recruiting
    • B-Cell Lymphoma
    • +4 more
    • 19(T2)28z1xx TRAC T cell
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Feb 24, 2023

    Chronic Lymphocytic Leukemia (CLL), Relapsed, Refractory Trial in New York (EGFRt/19-28z/4-1BBL CAR T cells)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +2 more
    • EGFRt/19-28z/4-1BBL CAR T cells
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Lymphoma
    • CD70-targeting CAR-T cells
    • Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 9, 2023

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous

    Active, not recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +4 more
    • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Mar 28, 2022

    Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Solid Tumor, Adult
    • CD70-targeting CAR-T cells
    • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 8, 2023

    T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • +3 more
    • Universal CD7-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 17, 2023

    Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • CD33KO-HSPC; CART33
    • (no location specified)
    Jul 13, 2023

    Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer Trial in Nanchang (CD70 CAR-T cells)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • CD70 CAR-T cells
    • Nanchang, Jiangxi, China
      The First Affiliated Hospital of Nanchang University
    Aug 23, 2023

    Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2022

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023